Position in INVA
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$953
-$1,493 QoQ
Shares Held
42
-60.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#287
of 306 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Valued Wealth Advisors LLC holds $51,022 across 9 Biotechnology names. INVA ranks #7 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
35 | $17,385 | |
| 2 | HRMY |
Harmony Biosciences Holdings, Inc.
|
351 | $12,779 | |
| 3 | EXEL |
Exelixis, Inc.
|
119 | $6,474 | |
| 4 | 158 | $4,965 | |||
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
20 | $4,819 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4 | $2,494 | |
| 7 | INVA |
Innoviva, Inc.
This page
|
42 | $953 | |
| 8 | GLUE |
Monte Rosa Therapeutics, Inc.
|
39 | $943 |
All Filings in INVA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $953 | 42 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $2,446 | 105 | Shares | Sole | 2026-04-30 | |
| No filing history on record for this holder in this stock. | ||||||